Career - Aug 10
Analysis: Furlough had a protective effect on mental health - but it wasn't as good as working
Analysis: Furlough had a protective effect on mental health - but it wasn't as good as working
Social Sciences - Aug 10
From fixer to reporter: After escaping the Taliban, University of Toronto's Jalal Nazari is on his way to becoming a journalist
From fixer to reporter: After escaping the Taliban, University of Toronto's Jalal Nazari is on his way to becoming a journalist
Environment - Aug 10
U-M study: Local renewable energy employment can fully replace U.S. coal jobs nationwide
U-M study: Local renewable energy employment can fully replace U.S. coal jobs nationwide
Sport - Aug 10
High school athletes in contact sports more likely to misuse prescription stimulants throughout their 20s
High school athletes in contact sports more likely to misuse prescription stimulants throughout their 20s
Social Sciences - Aug 9
Q and A with the experts: The role of Indigenous women in the preservation and transmission of traditional knowledge
Q and A with the experts: The role of Indigenous women in the preservation and transmission of traditional knowledge
Health - Aug 9
Most older adults ready to roll up sleeves this fall for updated COVID-19 boosters, U-M poll shows
Most older adults ready to roll up sleeves this fall for updated COVID-19 boosters, U-M poll shows
Astronomy - Aug 9
Invitation to media - Viewing Europe's MTG-I weather satellite before launch in Cannes
Invitation to media - Viewing Europe's MTG-I weather satellite before launch in Cannes
science wire
« BACK
Pharmacology - Health - 20.01.2022 
Mediterranean diet associated with a lower risk of mortality in older adults
A greater adherence to the Mediterranean diet which had been assessed through an index made with biomarkers during a 20-year scientific monitoring is associated with a lower mortality in adults over 65.
Health - Pharmacology - 19.01.2022 
The low-cost widely available drug that could fight COVID-19
A widely available and affordable drug, heparin, limits lung damage when inhaled by COVID-19 patients, according to world-first findings by researchers from The Australian National University (ANU).
Health - Pharmacology - 19.01.2022 
’Decoy’ protein works against multiple SARS-CoV-2 variants
A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers at the University of Illinois Chicago. The study suggests that the drug has the potential to treat COVID-19 patients, including those who are infected with aggressive SARS-CoV-2 variants.
Health - Pharmacology - 19.01.2022
Pharmacology - Health - 19.01.2022
Health - Pharmacology - 18.01.2022
Pharmacology - Health - 18.01.2022
Pharmacology - Health - 17.01.2022
Health - Pharmacology - 17.01.2022
Pharmacology - Health - 17.01.2022 
UCL startup acquired by biotechnology company in bid to find cancer drugs in ’record time’
Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory diseases.
Health - Pharmacology - 17.01.2022
Health - Pharmacology - 17.01.2022
Health - Pharmacology - 14.01.2022
Health - Pharmacology - 14.01.2022
Health - Pharmacology - 14.01.2022
Health - Pharmacology - 14.01.2022
Pharmacology - Health - 13.01.2022
Health - Pharmacology - 13.01.2022
Health - Pharmacology - 13.01.2022 
A spray to protect against lung damage from Covid-19
Rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases.
Health - Pharmacology - 13.01.2022 
COVID: why T cell vaccines could be the key to long-term immunity
With omicron having rapidly driven up COVID infections, attention is once again focusing on antibodies, and reasonably so.
Health - Pharmacology - 13.01.2022 
UHN and University of Toronto receive $24-million federal grant for transplant research
Researchers at University Health Network (UHN) and the University of Toronto have received $24 million to advance technology to repair and rebuild organs outside the body for patients in need.
Pharmacology - Health - 13.01.2022
Health - Pharmacology - 12.01.2022
Health - Pharmacology - 11.01.2022
Health - Pharmacology - 10.01.2022
Pharmacology - Health - 08.01.2022
Health - Pharmacology - 04.01.2022 
Early data for multivariant COVID-19 vaccine booster shows promise
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.
Health - Pharmacology - 04.01.2022 
UBC experts on COVID-19 pandemic
Media Advisories UBC Media Relations UBC experts are available to comment on the COVID-19 pandemic.
Health - Pharmacology - 04.01.2022
Health - Pharmacology - 03.01.2022
Health - Pharmacology - 24.12.2021
Pharmacology - Health - 23.12.2021 
Your daily medications could put you at greater risk of sunburn
With summer holidays underway, it's time to think about the sun and your skin, say researchers from the Sydney Pharmacy School.
Health - Pharmacology - 22.12.2021
Health - Pharmacology - 22.12.2021 
How our experts shaped the COVID-19 response
Perhaps more than ever before, 2021 saw an increased demand for our researchers' expertise. Governments, industry, and the public were hungry for a better understanding of the COVID-19 pandemic, as well as the way forward.
Pharmacology - Campus - 22.12.2021
Health - Pharmacology - 21.12.2021
Health - Pharmacology - 21.12.2021 
Cancer researchers across the UK join forces to find drugs for rare cancers
Cancer Research UK, The University of Manchester and Roche, today (Monday 20th), announce a partnership to run a multi-drug, precision medicine platform trial for adults and children with rare cancers who have run out of other treatment options.
Health - Pharmacology - 21.12.2021
Pharmacology - Pedagogy - 21.12.2021
Health - Pharmacology - 20.12.2021
Health - Pharmacology - 20.12.2021 
Covid-19 vaccine protection wanes after three months
Covid-19 vaccine protection wanes after three months, study suggests The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says. The findings - drawn from datasets in two countries - suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with Oxford-Astra Zeneca, experts say.
Health - Pharmacology - 17.12.2021
Health - Pharmacology - 17.12.2021
Health - Pharmacology - 16.12.2021
Health - Pharmacology - 16.12.2021
Health - Pharmacology - 16.12.2021
Pharmacology - Health - 16.12.2021
Pharmacology - Health - 15.12.2021 
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections.
Pharmacology - 15.12.2021
Pharmacology - Social Sciences - 15.12.2021
Pharmacology
Results 201 - 250 of 3006.
A greater adherence to the Mediterranean diet which had been assessed through an index made with biomarkers during a 20-year scientific monitoring is associated with a lower mortality in adults over 65.
A widely available and affordable drug, heparin, limits lung damage when inhaled by COVID-19 patients, according to world-first findings by researchers from The Australian National University (ANU).
A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers at the University of Illinois Chicago. The study suggests that the drug has the potential to treat COVID-19 patients, including those who are infected with aggressive SARS-CoV-2 variants.
Fungal infections in Africa: no adequate treatment despite millions of affected patients
Together with an international team of experts, Professor Dr Oliver Cornely, head of the European Excellence Center for Invasive Fungal Infections at University Hospital Cologne, has conducted a study to investigate the current situation of clinical mycology - the treatment of fungal diseases - on the African continent, revealing significant deficits.
Together with an international team of experts, Professor Dr Oliver Cornely, head of the European Excellence Center for Invasive Fungal Infections at University Hospital Cologne, has conducted a study to investigate the current situation of clinical mycology - the treatment of fungal diseases - on the African continent, revealing significant deficits.
Building Robust Collaborations to ’ATTACK’ Future Pandemics
California-based UC-NL ATTACK Consortium leverages novel science and technologies to accelerate drug discovery As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in the arsenal against the virus.
California-based UC-NL ATTACK Consortium leverages novel science and technologies to accelerate drug discovery As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in the arsenal against the virus.
Pressure leads GPs to increase antibiotic prescribing
The pressure GPs are working under has been linked to increasing broad-spectrum antibiotic prescribing in England by health economists at The University of Manchester and University of Southern Denmark.
The pressure GPs are working under has been linked to increasing broad-spectrum antibiotic prescribing in England by health economists at The University of Manchester and University of Southern Denmark.
Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of Warwick
Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the.
Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the.
Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory diseases.
Study brings life-saving diagnostic imaging closer to home for remote northern communities
Patients are the first in Canada to be scanned using state-of-the-art portable MRI Kingston, ON - Life in Ontario's far north brings with it unique challenges.
Patients are the first in Canada to be scanned using state-of-the-art portable MRI Kingston, ON - Life in Ontario's far north brings with it unique challenges.
Dramatic fall in hospital admissions for child infections since start of covid-19 pandemic
Since the onset of the covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measur
Since the onset of the covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measur
Rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases.
With omicron having rapidly driven up COVID infections, attention is once again focusing on antibodies, and reasonably so.
Researchers at University Health Network (UHN) and the University of Toronto have received $24 million to advance technology to repair and rebuild organs outside the body for patients in need.
UW Pharmacy’s Drug Interaction Database, built to promote medication safety, wins national innovation award
For more than 20 years, the University of Washington has been home to a database built, maintained and expanded around the goal of helping to prevent health complications from adverse drug reactions, one of the leading causes of injury and death in health care settings.
For more than 20 years, the University of Washington has been home to a database built, maintained and expanded around the goal of helping to prevent health complications from adverse drug reactions, one of the leading causes of injury and death in health care settings.
Second generation CAR T-cell therapy trialled in patients
A new CAR T-cell therapy developed by scientists at UCL has fewer 'toxic' side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase I clinical trial of patients at University College London Hospitals (UCLH).
A new CAR T-cell therapy developed by scientists at UCL has fewer 'toxic' side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase I clinical trial of patients at University College London Hospitals (UCLH).
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.
Media Advisories UBC Media Relations UBC experts are available to comment on the COVID-19 pandemic.
With summer holidays underway, it's time to think about the sun and your skin, say researchers from the Sydney Pharmacy School.
Perhaps more than ever before, 2021 saw an increased demand for our researchers' expertise. Governments, industry, and the public were hungry for a better understanding of the COVID-19 pandemic, as well as the way forward.
Cancer Research UK, The University of Manchester and Roche, today (Monday 20th), announce a partnership to run a multi-drug, precision medicine platform trial for adults and children with rare cancers who have run out of other treatment options.
Omicron may be significantly better at evading vaccine-induced immunity, but less likely to cause severe disease
The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs. Omicron's mutations present the virus with a double-edged sword: it's got better at evading the immune system, but it might have lost some of its ability to cause severe disease Ravi Gupta As the SARS-CoV-2 virus replicates and spreads, errors in its genetic code can lead to changes in the virus.
The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs. Omicron's mutations present the virus with a double-edged sword: it's got better at evading the immune system, but it might have lost some of its ability to cause severe disease Ravi Gupta As the SARS-CoV-2 virus replicates and spreads, errors in its genetic code can lead to changes in the virus.
Covid-19 vaccine protection wanes after three months, study suggests The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says. The findings - drawn from datasets in two countries - suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with Oxford-Astra Zeneca, experts say.
UCLA gene therapy gives new life to girl born with fatal immune disorder
After more than two years, the first child to receive the innovative treatment for LAD-1 remains healthy and disease-free After more than two years, the first child to receive the innovative treatmen
After more than two years, the first child to receive the innovative treatment for LAD-1 remains healthy and disease-free After more than two years, the first child to receive the innovative treatmen
Yale experts join campaign to boost vaccinations in communities of color
Faculty experts at Yale have partnered with Made to Save , a national campaign working to increase vaccinations in communities of color, to develop a new that helps doctors, nurses, and other health care professionals talk more effectively with patients about the COVID-19 vaccine.
Faculty experts at Yale have partnered with Made to Save , a national campaign working to increase vaccinations in communities of color, to develop a new that helps doctors, nurses, and other health care professionals talk more effectively with patients about the COVID-19 vaccine.
Needs of patients with opioid use disorder similar to other patients
With the magnitude of the opioid crisis, there has been a growing call for treatment of patients with opioid use disorder to be expanded beyond specialist care and into the hands of primary care physicians. Yet while primary care providers are positioned to offer these services - and are already allowed to prescribe buprenorphine and naloxone treatment - many choose not to, citing a lack of institutional support and discomfort managing the more complex medical needs sometimes associated with this disorder.
With the magnitude of the opioid crisis, there has been a growing call for treatment of patients with opioid use disorder to be expanded beyond specialist care and into the hands of primary care physicians. Yet while primary care providers are positioned to offer these services - and are already allowed to prescribe buprenorphine and naloxone treatment - many choose not to, citing a lack of institutional support and discomfort managing the more complex medical needs sometimes associated with this disorder.
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections.
Childhood trauma linked to psychotic symptoms in young cannabis users
Childhood trauma may increase the chance of young people experiencing psychotic symptoms when using cannabis, University of Queensland research has found.
Childhood trauma may increase the chance of young people experiencing psychotic symptoms when using cannabis, University of Queensland research has found.
Teen use of illicit drugs decreased in 2021, as the COVID-19 pandemic continued
Declines in adolescent use of illicit drugs reported in 2021 were the largest and most sweeping ever recorded in the past 46 years, according to the Monitoring the Future study.
Declines in adolescent use of illicit drugs reported in 2021 were the largest and most sweeping ever recorded in the past 46 years, according to the Monitoring the Future study.
Career - Aug 10
Analysis: Furlough had a protective effect on mental health - but it wasn't as good as working
Analysis: Furlough had a protective effect on mental health - but it wasn't as good as working
Social Sciences - Aug 10
From fixer to reporter: After escaping the Taliban, University of Toronto's Jalal Nazari is on his way to becoming a journalist
From fixer to reporter: After escaping the Taliban, University of Toronto's Jalal Nazari is on his way to becoming a journalist
Environment - Aug 10
U-M study: Local renewable energy employment can fully replace U.S. coal jobs nationwide
U-M study: Local renewable energy employment can fully replace U.S. coal jobs nationwide
Sport - Aug 10
High school athletes in contact sports more likely to misuse prescription stimulants throughout their 20s
High school athletes in contact sports more likely to misuse prescription stimulants throughout their 20s
Social Sciences - Aug 9
Q and A with the experts: The role of Indigenous women in the preservation and transmission of traditional knowledge
Q and A with the experts: The role of Indigenous women in the preservation and transmission of traditional knowledge
Health - Aug 9
Most older adults ready to roll up sleeves this fall for updated COVID-19 boosters, U-M poll shows
Most older adults ready to roll up sleeves this fall for updated COVID-19 boosters, U-M poll shows
Astronomy - Aug 9
Invitation to media - Viewing Europe's MTG-I weather satellite before launch in Cannes
Invitation to media - Viewing Europe's MTG-I weather satellite before launch in Cannes